Prostate cancer: open trials in Puerto Rico

12 open trials have a site in Puerto Rico. Registry data; only the trial team decides who can take part.

NCT06136624
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Puerto Rico Medical Research Center LLC (Site 1354), Hato Rey · Ad-Vance Medical Research-Research (Site 1353), Ponce · Pan American Center for Oncology Trials - Ciudadela (Site 1351), San Juan
Registry updated 2026-11-05
NCT03866382
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Trial Treatment · Phase 2 · National Cancer Institute (NCI)
Pan American Center for Oncology Trials LLC, San Juan
Registry updated 2026-11-04
NCT07164443
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Pan American Center for Oncology Trials LLC, Rio Piedras · Puerto Rico Medical Research Center, San Juan
Registry updated 2026-11-03
NCT07225946
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Pan American Center for Oncology Trials LLC, San Juan
Registry updated 2026-11-03
NCT07723248
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
Trial Treatment · Phase 3 · ORIC Pharmaceuticals
BRCR Global (Network), San Juan
Registry updated 2026-11-03
NCT05939414
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
VA Caribbean Healthcare System, San Juan
Registry updated 2026-10-21
NCT06136650
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Ad-Vance Medical Research-Research (Site 1177), Ponce · Advance Urology and Laparoscopic Center (Site 1178), Ponce · Pan American Center for Oncology Trials - Ciudadela (Site 1176), San Juan
Registry updated 2026-10-20
NCT07711002
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
Trial Treatment · Phase 3 · AstraZeneca
Rio Piedras
Registry updated 2026-10-15
NCT06056830
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Trial Treatment · Phase 3 · Clarity Pharmaceuticals Ltd
Pan American Center for Oncology Trials LLC - Ciudadela, San Juan
Registry updated 2026-09-11
NCT07005154
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Trial Treatment · Phase 2 · Astellas Pharma Global Development, Inc.
PanOncology Trials, San Juan
Registry updated 2026-09-03
NCT04729114
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Trial Treatment · Phase 1 · Astellas Pharma Global Development, Inc.
Pan American Center for Oncology Trials LLC, San Juan
Registry updated 2026-02-04
NCT03452774
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Research · Massive Bio, Inc.
San Juan
Registry updated 2025-10-28

All Prostate cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error